Anti-HCV
Screen Rate
Anti-HCV(+)
Prevalence
HCV-RNA
Test Rate
Diagnosis
Rate
Treatment
Rate
0
100
0
100
0
100
0
100
0
100
0
100
Nation-wide
Anti-HCV
Screen Rate

58.8%

Nation-wide
Diagnosis
Rate

38.3%

Nation-wide
Treatment
Rate

95.2%

Nation-wide
Effectiveness1

36.5%

Target population
for Anti-HCV
screening2

10,052,375

Accumulative
No. of Anti-HCV
screened3

5,912,096

Accumulative
No. of HCV-RNA
tested3

307,077

Accumulative No.
of Treated (DAA
and/or Interferon)3

184,099

1. ML Yu, et al. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan. Medicine 2015 (94): 13: e690
2. Taiwan government provides free screening for age group of 45-79 year-old.
3. The cumulative number of screenings and treatments, including all individuals aged 45-79, data extracted until June 30, 2023.

Progress of HCV elimination in Taiwan Counties